Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

Megalin Is Essential for Renal Proximal Tubule Reabsorption of 111In-DTPA-Octreotide

Marion de Jong, Raffaella Barone, Eric Krenning, Bert Bernard, Marleen Melis, Theo Visser, Michael Gekle, Thomas E. Willnow, Stephan Walrand, François Jamar and Stanislas Pauwels
Journal of Nuclear Medicine October 2005, 46 (10) 1696-1700;
Marion de Jong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raffaella Barone
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Krenning
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bert Bernard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marleen Melis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theo Visser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Gekle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas E. Willnow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan Walrand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Jamar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanislas Pauwels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Radiolabeled somatostatin analogs have been shown to be important radiopharmaceuticals for tumor diagnosis and radionuclide therapy. The kidney has appeared to be the critical organ during radionuclide therapy because of peptide reabsorption and retention in the proximal tubules after glomerular filtration. The molecular mechanism of renal reabsorption of these analogs has not been clarified. A possible receptor candidate is megalin, a multiligand scavenger receptor in the renal proximal tubules. The objective of this study was to investigate the role of megalin in tubular reabsorption of radiolabeled somatostatin analogs by using kidney-specific megalin-deficient mice versus mice with normal renal megalin expression. [111In-Diethylenetriaminepentaacetic acid (DTPA)]octreotide was used as a practical model of peptide. Methods: Renal uptake of [111In-DTPA]octreotide was determined by animal SPECT scintigraphy at different time points after injection of the tracer and by measurement of radioactivity after isolation of the organs. Furthermore, ex vivo autoradiography of renal sections revealed the zonal distribution of radioactivity in the megalin-deficient and megalin-expressing kidneys. Results: SPECT scintigraphy of [111In-DTPA]octreotide at 3 and 24 h after injection clearly showed lower renal radioactivity in megalin-deficient kidneys than in megalin-expressing kidneys, both in male and in female mice, in accordance with counts obtained after isolation of the organ (70%–85% reduction of uptake in the megalin-deficient kidneys, P < 0.001). Renal uptake of [111In-DTPA]octreotide was significantly higher in female than in male kidneys (P < 0.001). Ex vivo autoradiograms clearly showed that renal radioactivity was not homogeneously distributed in the megalin-expressing kidneys but localized in the renal cortex. Quantification of the autoradiogram data confirmed the reduced radioactivity in the renal cortex of megalin-deficient kidneys. Conclusion: This study revealed the molecular mechanism of [111In-DTPA]octreotide uptake in renal proximal tubules involving the receptor megalin. Identification of megalin may be crucial for further research into strategies to reduce renal uptake.

  • megalin
  • [111In-DTPA]octreotide
  • kidney
  • tubular reabsorption

Footnotes

  • Received Apr. 30, 2005; revision accepted Jun. 9, 2005.

    For correspondence or reprints contact: Marion de Jong, PhD, Department of Nuclear Medicine, Erasmus MC Rotterdam, dr Molewaterplein 40, Rotterdam, 3015 gd, The Netherlands.

    E-mail: m.hendriks-dejong{at}erasmusmc.nl

View Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (10)
Journal of Nuclear Medicine
Vol. 46, Issue 10
October 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Megalin Is Essential for Renal Proximal Tubule Reabsorption of 111In-DTPA-Octreotide
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Megalin Is Essential for Renal Proximal Tubule Reabsorption of 111In-DTPA-Octreotide
Marion de Jong, Raffaella Barone, Eric Krenning, Bert Bernard, Marleen Melis, Theo Visser, Michael Gekle, Thomas E. Willnow, Stephan Walrand, François Jamar, Stanislas Pauwels
Journal of Nuclear Medicine Oct 2005, 46 (10) 1696-1700;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Megalin Is Essential for Renal Proximal Tubule Reabsorption of 111In-DTPA-Octreotide
Marion de Jong, Raffaella Barone, Eric Krenning, Bert Bernard, Marleen Melis, Theo Visser, Michael Gekle, Thomas E. Willnow, Stephan Walrand, François Jamar, Stanislas Pauwels
Journal of Nuclear Medicine Oct 2005, 46 (10) 1696-1700;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model
  • Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin Lymphoma
  • Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
  • Different Radioactivity Uptake between Somatostatin Analogues Labelled with 111In and 90/88Y in Rat Kidney
  • Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
  • Nephrotoxicity in Mice After Repeated Imaging Using 111In-Labeled Peptides
  • Biodistribution of Two Octreotate Analogs Radiolabeled with Indium and Yttrium in Rats
  • Reducing Renal Uptake of Radiolabeled Peptides Using Albumin Fragments
  • Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides
  • Inhibition of Kidney Uptake of Radiolabeled Somatostatin Analogs: Amino Acids or Gelofusine?
  • 177Lu-AMBA: Synthesis and Characterization of a Selective 177Lu-Labeled GRP-R Agonist for Systemic Radiotherapy of Prostate Cancer
  • Renal Uptake of Radiolabeled Octreotide in Human Subjects Is Efficiently Inhibited by Succinylated Gelatin
  • Google Scholar

More in this TOC Section

  • Tumor Uptake of Anti-CD20 Fabs Depends on Tumor Perfusion
  • How Sensitive Is the Upper Gastrointestinal Tract to 90Y Radioembolization? A Histologic and Dosimetric Analysis in a Porcine Model
  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire